ILMN vs MLYS · rev $2.25B vs $2.17B cap
Illumina Inc (ILMN) versus Mineralys Therapeutics, Inc. Common Stock (MLYS) — a side-by-side from cached financials, not a winner call.
Illumina Inc (ILMN) is a diagnostics & research company listed on US.
Mineralys Therapeutics, Inc. Common Stock (MLYS) is a biotechnology company listed on US.
Latest reported ILMN revenue for 2026-06-28 was $2.25B. Net income was $340.0M. ILMN currently screens at market cap $15.84B.
MLYS does not have a complete income-statement cache yet.
ILMN currently screens at market cap $15.84B. MLYS currently screens at market cap $2.17B.
Not investment advice. Open the ILMN and MLYS stock pages for the full models.
Not investment advice.